Bill
HD 139
Massachusetts bill to expand sickle cell disease screening, treatment access, and patient support services to reduce disparities and improve health outcomes.
HD 139 would establish comprehensive improvements to sickle cell disease care and support in Massachusetts, likely including enhanced screening, treatment access, and patient support services. The bill aims to address disparities in sickle cell care, which disproportionately affects African American and other minority populations. Specific provisions would typically address newborn screening, insurance coverage, specialist availability, and patient education resources.
Sickle cell disease causes significant morbidity and mortality, with affected individuals often facing barriers to specialized care and higher healthcare costs. Massachusetts has a substantial population with sickle cell disease, and improving care infrastructure can reduce complications, hospitalizations, and premature deaths. Better care coordination and access also reduce long-term healthcare system costs while improving quality of life for patients and families.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
